| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.03 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.095 | 0.03 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.3 | 0.03 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.03 |